HGRVF yields 7.05% · PFE yields 6.13%● Live data
📍 HGRVF pulled ahead of the other in Year 1
Combined, HGRVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HGRVF + PFE for your $10,000?
Hargreaves Services Plc provides environmental and industrial services in the United Kingdom, Europe, Hong Kong, and internationally. It operates through Services, Hargreaves Land, and Hargreaves Raw Materials Services segments. The company offers environmental services, such as carbon sequestration and forestry creation, land remediation, land restoration and aftercare, geotechnical assessment, environmental site survey, and waste management services; materials handling operation and maintenance, mechanical and electrical maintenance, and project engineering services; and earthmoving advisory and contracting services, including soils treatment services. It also engages in the logistics services and mining and quarrying services. In addition, the company develops brownfield site for residential and commercial purposes; and engages in the trading of industrial raw materials, such as solid fuels, refractory minerals, and pig iron, as well as ferro-alloys and metals. Hargreaves Services Plc was founded in 1994 and is headquartered in Durham, the United Kingdom.
Full HGRVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.